Workers’ Comprehensive

News and views in workers’ comp
Important news in workers’ comp delivered to your inbox
Subscribe

Search Workers' Comprehensive Articles

  • Reset
NWCDC
In Case You Missed It: 5 Takeaways on Value-Based Models in Work Comp

Dr. Silvia Sacalis of Healthesystems teamed up with Dr. Adam Seidner of The Hartford for a session at NWCDC – here are 5 key takeaways.

Read More →
Medmonitor
FDA Approves New Opioid, Dsuvia

Five-to-ten times stronger than fentanyl, this drug is not for consumer use, and many claim it could worsen the opioid crisis.

Read More →
This Month's Must Read
The Opioid Crisis: Our Defining Moment

Healthesystems’ clinical leaders comment on the collective responsibility of healthcare entities, providers, and legislators to increase efforts that will help stem opioid overprescribing, misuse and overdose.

Read More →
Marijuana Updates
Midterm Marijuana Updates

More states allow for the legalization of recreational and medical marijuana, while others consider insurance reimbursement.

Read More →
Clinical Insights
JAMA Examines Persistent Opioid Use in Workers’ Comp Patients

A study of 9,596 claimants who filled an opioid prescription found that 30% were still taking opioids 90 days later.

Read More →
Healthe Developments
Healthesystems at NWCDC 2018

Join our VP of Clinical Services on December 6th in Las Vegas for a presentation on value-based care in workers’ comp.

Read More →
Medmonitor
DEA Reschedules Epidiolex

The marijuana-derived seizure drug now sits at schedule V, facing far fewer prescribing and dispensing restrictions.

Read More →
This Month's Must Read
Dr. Silvia Sacalis Discusses Medication Red Flags with Risk & Insurance

Healthesystems’ VP of Clinical Services offers insight into prescriptions in workers’ comp claims that should raise concerns.

Read More →
Legislation & Policy
New Jersey Bill Pushes for Medical Marijuana Reimbursement

Assembly No. 4505 may solidify precedence recently made by a judge from the Division of Workers’ Compensation.

Read More →
Industry Trends
National Safety Council Issues Report on Workplace Fatigue

Common risk factors can increase worker fatigue, leading to more frequent workplace injuries and a loss of productivity.

Read More →
Opioid Developments
Federal Opioid Reform Bill Signed into Law

With an enormous range of initiatives to prevent and treat opioid use disorder, the bill has officially been signed by the President.

Read More →
Medmonitor
FDA Approves New Dosage for Opioid Dependence Therapy

Cassipa (buprenorphine and naloxone) sublingual film delivers a new dosage for the treatment of opioid dependence.

Read More →
This Month's Must Read
Dr. Silvia Sacalis Discusses Polypharmacy with WC Magazine

Healthesystems’ VP of Clinical Services explains how too many drugs in a claim can cause health concerns, and what can be done to prevent them.

Read More →
Legislation & Policy
FDA Reassesses Opioid Policies

The FDA is working to create new opioid prescribing practices and guidelines, while also shifting drug development priorities for pain medications.

Read More →
Clinical Insights
CWCI Releases Polypharmacy Report

According to 2016-2017 data, over 20% of polypharmacy claims are over 10 years old, with more than 50% of them for patients aged 50 and older.

Read More →
Opioid Developments
Massachusetts Study Links Occupation to Opioid Overdose Deaths

On average, construction workers are six times more likely to die from an opioid overdose death, more than any other occupation.

Read More →
Healthe Developments
Dr. Robert Goldberg Comments on DEA Opioid Manufacturing Quotas

Healthesystems’ Chief Medical Officer spoke with WorkCompCentral regarding DEA plans to reduce opioid manufacturing.

Read More →
Medmonitor
FDA Accepts New Drug Application for Opioid NKTR-181

NKTR-181 is supposed to offer a lower frequency of opioid side effects. But are more opioids really the solution we need to the opioid crisis?

Read More →
This Month's Must Read
Sandy Shtab Discusses the Need to Modernize Regulation with WorkCompWire

Healthesystems’ AVP of Advocacy & Compliance explains how regulation has been unable to keep pace with healthcare innovation & technology.

Read More →
Legislation & Policy
PTSD Legislation Continues to Grow

More states cover PTSD without physical injuries for first responders, and 24 states allow PTSD patients to use medical marijuana.

Read More →
Clinical Insights
New Developments in Migraine Medications

A new wave of drugs that suppress CGRP proteins to reduce migraines could be on the horizon.

Read More →
Opioid Developments
FDA Proposes New Clinical Endpoints for Development of Opioid-Use Disorder Drugs

Drugs to treat opioid dependence could be approved under new clinical endpoints other than reducing opioid use.

Read More →
Healthe Developments
Healthe Clinical Leaders in the News

Our Chief Medical Officer and VP of Clinical Services comment on matters such as the use of anticonvulsants to treat pain and opioid prescriptions for inpatients.

Read More →
Medmonitor
New Opioid in Development May Offer Reduced Risk Profile

Phase 2/3 clinical trial results for Korsuva demonstrate pain relief with fewer side effects.

Read More →
This Month's Must Read
Mark of the Millennial: Managed Care for a New Generation

Millennials are more diverse and more open to alternative therapies, medical marijuana, healthcare technology, and dialogue surrounding psychosocial concerns.

Read More →
Legislation & Policy
Support for Marijuana Continues to Grow Across the Nation

A flurry of recent developments continues to bring the medical marijuana debate front and center, including further legalization, a Senate bill, a drug approval, and more.

Read More →
Clinical Insights
JAMA Study Questions the Effectiveness of Negative Pressure Wound Therapy

In a randomized clinical trial of 460 patients, researchers found the treatment to have similar impact on self-rated disability as standard wound dressing.

Read More →
Healthe Developments
Healthesystems at WCIEC Orlando 2018

Visit Healthesystems in booth #914 to see how we explore the conference’s “Cosmic” theme, and for a chance to win a $250 gift card.

Read More →
Medmonitor
Drug Approvals Impacting Workers’ Comp

The FDA recently approved drugs to treat opioid dependence, migraines, and rheumatoid arthritis.

Read More →
This Month's Must Read
The Burden of Opioid-Related Mortality in the United States

Among many findings, JAMA reports that 20% of deaths among those aged 25-34 were opioid-related.

Read More →
Legislation & Policy
More States Pass Opioid Prescription Limits

Within the last month, laws have passed in Tennessee, Colorado, South Carolina, Oklahoma, and Hawaii.

Read More →
Clinical Insights
IQVIA Reports on Global Oncology Trends

Global spending on cancer therapies now exceeds $133 billion.

Read More →
Healthe Developments
Healthe Leaders Comment on Clinical Use of Marijuana & MDMA

Our Chief Medical Officer and VP of Clinical Services comment on the clinical use of ecstasy and marijuana.

Read More →
Medmonitor
FDA Encourages Drug Developers to Focus on Buprenorphine Depot Products

A newly released draft guidance encourages the development of more sustained-release buprenorphine products.

Read More →
This Month's Must Read
WCRI Releases CompScope Benchmarks

In-depth reports for 16 different states examine medical payments, costs, duration of disability, and more.

Read More →
Legislation & Policy
Illinois Bill May Allow Patients to Trade Opioids for Marijuana

Senate Bill 336 passed with a 44-6 vote and is now headed to the House.

Read More →
Clinical Insights
The Craze Over Kratom

Kratom continues to grow in popularity as a drug for pain and opioid withdrawal, despite concerns from the FDA, CDC and DEA.

Read More →
Healthe Developments
Four Current and Near-Future Drug Trends Impacting Rx Management

In a special partner post with WorkCompWire, Healthesystems discusses developments in pain management, specialty drugs, and more.

Read More →
Medmonitor
Opioid Withdrawal Drug Closer to Approval

If approved, Lucemyra (lofexidine) would be the first non-opioid drug approved to treat the symptoms of opioid withdrawal.

Read More →
This Month's Must Read
Dr. Silvia Sacalis Discusses Value-Based Care with WorkCompWire

Healthesystems’ VP of Clinical Services discusses how workers’ comp is embracing a value-driven approach.

Read More →
Clinical Insights
WCIRB Reports on Chronic Opioid Use and Weaning

A new study analyzes the characteristics of chronic opioid use claims, while also examining opioid weaning data.

Read More →
Legislation & Policy
PTSD Bills Gain Momentum in Workers’ Comp

A Florida bill was recently signed into law, and states such as Arizona, Utah, Connecticut, and Oregon may follow suit.

Read More →
Legislation & Policy
More States Embrace Closed Drug Formularies

Indiana and Kentucky signed off on formulary bills, while other states continue to make progress on their promised formularies.

Read More →
Healthe Developments
Dr. Robert Goldberg to Speak at IRSG

Healthesystems’ Chief Medical Officer will present "Can Workers’ Comp Catch Up to the Rest of Healthcare?" at the 2018 IRSG Annual Conference.

Read More →
Medmonitor
FDA Approves New Opioid Prodrug, Apadaz

Apadaz oral tablets were approved for the short-term management of acute pain, at no more than 14 days of use.

Read More →
Healthe Developments
Dr. Silvia Sacalis to Speak at National Rx Drug Abuse & Heroin Summit

Healthesystems' VP of Clinical Services will co-present Workers' Comp Opioid Use Trends and Effective Population Health Management

Read More →
Opioid Developments
Ohio BWC Reports Falling Levels of Opioid Dependence

The number of opioid-dependent injured workers in the Ohio workers' comp system fell 19% in 2017.

Read More →
Legislation & Policy
Air Ambulances: State v Federal Cost Control

Many states have attempted to implement fee schedules for air ambulances, but courts citing federal regulations have stricken them down.

Read More →
Opioid Developments
State and City Lawsuits Continue to Mount Against Opioid Manufacturers

Forty-one states and over 200 cities and counties claim drug makers deceived patients and doctors regarding opioid safety and addiction risks.

Read More →
Medmonitor
Drug Recalls Impacting Comp

Senna Laxative bottles were found to contain NSAIDs, while 55 lots of compounded drugs face questionable sterility.

Read More →
This Month's Must Read
Medication Multiplication

A visual depiction of how opioid side effects can cascade across the body.

Read More →
Clinical Insights
Increased Abuse Among Anti-Diarrhea Drugs

When taken in excessive doses, the anti-diarrhea drug loperamide can mimic opioid euphoria, and toxicity events and deaths are on the rise.

Read More →
Legislation & Policy
State Legislatures Increase Action Against Opioid Epidemic

The passage of opioid action plans in Arizona, Tennessee, and Pennsylvania are the most recent additions to growing statewide efforts to curb the epidemic.

Read More →
Industry Trends
The Rise of the Gig Economy

In 2003, gig workers made up less than 5% of the workforce. Today, estimates vary between 8% and 40%, raising questions for comp.

Read More →
Medmonitor
FDA Continues to Shift Opioid Strategy

FDA, opioid, opioids, opioid policy, opioid policies, drug development, non-opioid

Read More →
Innovation
Artificial Intelligence and Workers’ Comp

Machine learning aims to automate parts of claims management.

Read More →
Clinical Insights
No End in Sight for the Opioid Epidemic?

Despite decreases in prescribing rates, the opioid epidemic claims more lives than ever before, partially due to synthetic formulations.

Read More →
Legislation & Policy
State and Federal Governments Clash Over Marijuana

The Department of Justice’s recent announcement may come to a head with the will of state governments and popular opinion.

Read More →
Industry Trends
March of the Millennials

By 2020, millennials will make up half the workforce, so how will they impact workers’ comp?

Read More →
1 4 5 6

Workers’ Comprehensive

News and views in workers’ comp
Important news in workers’ comp delivered to your inbox
Subscribe
Back to Top
lockenvelopephone-handsetmagnifiercrossmenucross-circle